Abbott Laboratories
ABT
$87.77
-$0.61-0.69%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.57% | 0.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.57% | 0.79% | |||
| Cost of Revenue | -0.47% | -3.19% | |||
| Gross Profit | -4.16% | 4.00% | |||
| SG&A Expenses | 22.34% | 0.83% | |||
| Depreciation & Amortization | 0.00% | 0.48% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.55% | -1.99% | |||
| Operating Income | -39.28% | 12.34% | |||
| Income Before Tax | -38.55% | 8.17% | |||
| Income Tax Expenses | -36.08% | 8.58% | |||
| Earnings from Continuing Operations | -39.36% | 8.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.36% | 8.03% | |||
| EBIT | -39.28% | 12.34% | |||
| EBITDA | -29.43% | 9.11% | |||
| EPS Basic | -38.37% | 6.27% | |||
| Normalized Basic EPS | -40.34% | 11.38% | |||
| EPS Diluted | -39.18% | 6.69% | |||
| Normalized Diluted EPS | -40.49% | 11.84% | |||
| Average Basic Shares Outstanding | -0.26% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.13% | |||
| Dividend Per Share | 0.00% | 6.78% | |||
| Payout Ratio | 0.76% | -0.08% | |||